BioSpace News Archive

Alithya Group inc. (TSX: ALYA) (NASDAQ: ALYA) (“Alithya”), a leader in digital strategy and technologies employing more than 2,000 highly qualified professionals offering enterprise solutions across Canada, the United States, and Europe, is proud to announce the acquisition of Travercent LLC, (“Travercent ").

Platelet BioGenesis, Inc. (PBG), the leader in stem cell-derived, on-demand human platelets (PLTs+™) and genetically engineered platelet-based therapeutics, announced today it received an award of $2.3 million from the Medical Technology Enterprise Consortium (MTEC) – a 501(c)(3) biomedical technology consortium collaborating with the U.S. Army Medical Research and Development Command (USAMRDC)

NewLink Genetics Corporation (NASDAQ:NLNK) (“NewLink” or the “Company”) today publicly announced its rejection of the unsolicited acquisition proposal received on November 5, 2019 from Evercel, Inc. (“Evercel”) (OTC:EVRC), a holding company with a primary operating business selling line matrix printers and accessories.

Encompass Health (NYSE: EHC) today announced the appointment of Anthony “Tony” Hernandez as chief human resources officer, effective Jan. 6, 2020.

Promethera® Biosciences SA announced the addition of €7.5 million to its recent €39.7 million Series D financing led by new investors Sony Innovation Fund by IGV and Pegasus Tech Ventures.

IRRAS announced the launch of its Hummingbird® ICP Monitoring product family in the United States.

ADAMA Ltd., announced that it has successfully obtained regulatory approval in its first market, Paraguay, for ARMERO™, its new dual-mode fungicide containing the active ingredients prothioconazole and mancozeb, benefiting from its new in-house production of prothioconazole, a broad-spectrum systemic fungicide.

FSD Pharma Inc. announces that Nasdaq has approved its application to have its Class B Subordinate Voting Shares listed on the Nasdaq Capital Market.

Mauna Kea Technologies inventor of Cellvizio®, the multidisciplinary probe and needle-based confocal laser endomicroscopy platform, today announced a strategic equity investment of 7.5 million euro by Johnson & Johnson Innovation – JJDC, Inc..

PENTAX Medical, a division of the HOYA Group, announced that it has cleared CE mark for DISCOVERY™, an innovative Artificial Intelligence assisted polyp detector designed to support endoscopists in finding potential polyps during a colorectal examination.